0	1	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 3), 'text':'A Novel B Lymphocyte'}, {'start':(0, 4), 'end':(0, 17), 'text':'Associated Adaptor Protein , Bam32 , Regulates Antigen Receptor Signaling Downstream of Phosphatidylinositol 3-Kinase'}]}
9	30	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 14), 'text':'The population of B lymphocytes present in peripheral lymphoid tissues is dynamically maintained by processes'}, {'start':(1, 15), 'end':(1, 37), 'text':'that balance the continuous output from the bone marrow and proliferation in response to antigens with B cell terminal differentiation and death .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 20), 'text':'The choices between the alternative fates of proliferation , differentiation , and death , are largely determined by intracellular signaling cascades'}, {'start':(2, 21), 'end':(2, 25), 'text':'triggered by receptor-ligand interactions .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 16), 'text':'The B cell antigen receptor ( BCR ) is a central regulator of B cell fate .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 20), 'text':'BCR signaling is required for survival and recirculation of naive B cells as well as for antigen specific immune responses .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'condition', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 9), 'text':'Ligation of the BCR by antigen can have different outcomes'}, {'start':(5, 10), 'end':(5, 34), 'text':'depending on the differentiation stage of the B cell , the molecular form of antigen , and the immunological context of the antigen encounter .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 13), 'text':'These different outcomes can be due to differences in quality or quantity of signals'}, {'start':(6, 14), 'end':(6, 44), 'text':'emanating from the BCR itself and and or differential signaling through other key receptors such as CD19 , CD22 , CD40 , CD72 , CD95 , CDw150 , and FcgammaRII .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 18), 'text':'These coreceptors can act by directly modifying receptor proximal events in BCR signaling or by activating additional signaling pathways'}, {'start':(7, 19), 'end':(7, 26), 'text':'which influence the outcome of BCR signaling .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 11), 'text':'Ligation of the BCR leads to activation of nonreceptor protein tyrosine kinases'}, {'start':(8, 12), 'end':(8, 15), 'text':'( PTKs ) ,'}]}, {'start':(8, 16), 'end':(8, 22), 'text':'which regulate several downstream signaling pathways .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 3), 'text':'These include phospholipase C'}, {'start':(9, 4), 'end':(9, 8), 'text':'( PLC ) gamma ,'}]}, {'start':(9, 9), 'end':(9, 24), 'text':'which , upon activation , hydrolyzes phosphatidylinositol bisphosphate ( PI ( 4,5 ) P 2 )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 25), 'end':(9, 29), 'text':'to produce inositol 1,4,5 trisphosphate'}, {'start':(9, 30), 'end':(9, 34), 'text':'( IP 3 ) ,'}]}]}, {'start':(9, 35), 'end':(9, 46), 'text':'which triggers the release of calcium from intracellular stores , and diacylglycerol'}]}, {'start':(9, 47), 'end':(9, 50), 'text':'( DAG ) ,'}]}, {'start':(9, 51), 'end':(9, 58), 'text':'which can activate protein kinase C isoforms .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 1), 'text':'Other pathways'}, {'start':(10, 2), 'end':(10, 20), 'text':'that are activated downstream of PTKs include the Ras pathway and the phosphatidylinositol 3-kinase ( PI3K ) pathway .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 12), 'text':'Activation of PI3K leads to activation of the serine and threonine kinase Akt'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 13), 'end':(11, 29), 'text':'and regulates the membrane association and function of the Tec family PTK , Bruton \'s tyrosine kinase'}, {'start':(11, 30), 'end':(11, 33), 'text':'( Btk ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 10), 'text':'Adaptor proteins such as B cell linker ( BLNK ) ,'}, {'start':(12, 11), 'end':(12, 21), 'text':'which contain protein protein interaction domains but no catalytic activity ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 22), 'end':(12, 24), 'text':'play critical roles'}, {'start':(12, 25), 'end':(12, 34), 'text':'in linking BCR induced PTK activation to downstream effectors .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 27), 'text':'The BCR signaling cascade ultimately leads to activation of transcription factors such as nuclear factor of activated T cells ( NF-AT ) and nuclear factor of kappa binding'}, {'start':(13, 28), 'end':(13, 31), 'text':'( NF-kappaB ) .'}]}, {'start':(14, 0), 'end':(14, 19), 'text':'In at least one case , alternative outcomes of BCR signaling correlate with differential activation of these transcription factors .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 19), 'text':'During B cell responses to thymus dependent antigens , key B cell activation and differentiation events occur within germinal centers'}, {'start':(15, 20), 'end':(15, 23), 'text':'( GCs ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 4), 'text':'The GC response is initiated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 5), 'end':(16, 7), 'text':'when B cells'}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 8), 'end':(16, 23), 'text':'activated by encounter with antigen and cognate T cell help migrate to the B cell follicles'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 24), 'end':(16, 38), 'text':'and begin proliferating rapidly in association with the follicular dendritic cell ( FDC ) network'}, {'start':(16, 39), 'end':(16, 45), 'text':'to give rise to a GC .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 7), 'text':'GC B cells begin a complex differentiation program'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 8), 'end':(17, 11), 'text':'that incorporates somatic hypermutation'}, {'start':(17, 12), 'end':(17, 34), 'text':'coupled with selection for high-affinity antigen specific Ig , Ig class switching , and differentiation into memory B cells or plasma cells .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 7), 'text':'GC B cells represent a distinct differentiation state'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 8), 'end':(18, 22), 'text':'and display several unique properties such as a predisposition to apoptosis and reexpression of genes'}, {'start':(18, 23), 'end':(18, 29), 'text':'expressed during early B cell development .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 9), 'text':'The molecular basis for B cell activation and differentiation processes'}, {'start':(19, 10), 'end':(19, 16), 'text':'occurring within GCs is poorly understood .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 0), 'end':(20, 12), 'text':'In this study , we have undertaken a screen for GC associated genes'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 13), 'end':(20, 26), 'text':'and report the identification and characterization of a novel B cell restricted signaling molecule'}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 27), 'end':(20, 34), 'text':'that is highly expressed in GC B cells'}, {'start':(20, 35), 'end':(20, 46), 'text':'and appears to regulate B cell activation pathways downstream of PI3K .'}]}]}]}]}]}]}]}]}
1	9	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'We have identified'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 3), 'end':(0, 19), 'text':'and characterized a novel src homology 2 ( SH2 ) and pleckstrin homology ( PH ) domain'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 20), 'end':(0, 23), 'text':'containing adaptor protein ,'}, {'start':(0, 24), 'end':(0, 36), 'text':'designated Bam32 ( for B cell adaptor molecule of 32 kD ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 0), 'text':'cDNAs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 1), 'end':(1, 6), 'text':'encoding the human and mouse Bam32'}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 7), 'end':(1, 10), 'text':'coding sequences were isolated'}, {'start':(1, 11), 'end':(1, 21), 'text':'and the human bam32 gene was mapped to chromosome 4q25-q27 .'}]}]}]}, {'start':(2, 0), 'end':(2, 14), 'text':'Bam32 is expressed by B lymphocytes , but not T lymphocytes or nonhematopoietic cells .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 9), 'text':'Human germinal center B cells show increased Bam32 expression ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 10), 'end':(3, 18), 'text':'and resting B cells rapidly upregulate expression of Bam32'}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 19), 'end':(3, 43), 'text':'after ligation of CD40 , but not immunoglobulin M. Bam32 is tyrosine phosphorylated upon B cell antigen receptor ( BCR ) ligation or pervanadate stimulation'}, {'start':(3, 44), 'end':(3, 49), 'text':'and associates with phospholipase Cgamma2 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 15), 'text':'After BCR ligation , Bam32 is recruited to the plasma membrane through its PH domain .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 20), 'text':'Membrane recruitment requires phosphatidylinositol 3-kinase ( PI3K ) activity and an intact PI ( 3,4,5 ) P 3 -binding motif ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 21), 'end':(5, 21), 'text':'suggesting'}, {'start':(5, 22), 'end':(5, 30), 'text':'that membrane association occurs through binding to 3-phosphoinositides .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 22), 'text':'Expression of Bam32 in B cells leads to a dose dependent inhibition of BCR induced activation of nuclear factor of activated T cells'}, {'start':(6, 23), 'end':(6, 26), 'text':'( NF-AT ) ,'}]}, {'start':(6, 27), 'end':(6, 48), 'text':'which is blocked by deletion of the PH domain or mutation of the PI ( 3,4,5 ) P 3 -binding motif .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 9), 'text':'Thus , Bam32 represents a novel B cell associated adaptor'}, {'start':(7, 10), 'end':(7, 17), 'text':'that regulates BCR signaling downstream of PI3K .'}]}]}]}]}]}
169	244	{'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 21), 'text':'Studies of genetically deficient animals or humans have implicated adaptor proteins as critical regulators and integrators of signaling pathways in lymphocytes .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 2), 'text':'The Bam32 molecule'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 3), 'end':(2, 23), 'text':'described in this report represents a new and unique addition to the growing family of hematopoietic cell restricted signaling adaptor proteins'}, {'start':(2, 24), 'end':(2, 29), 'text':'that regulate lymphocyte signal transduction .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 11), 'text':'Compared with the known group of hematopoietic cell restricted adaptor proteins ,'}, {'start':(3, 12), 'end':(3, 24), 'text':'Bam32 is distinguished by its small size and its simple two-domain structure .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 21), 'text':'Perhaps due to this compact structure , the Bam32 amino acid sequence is highly conserved between different species , with mouse Bam32'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 22), 'end':(4, 33), 'text':'showing > 90 % identity to human ( ) and chicken Bam32'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 34), 'end':(4, 40), 'text':'showing > 80 % identity to human'}, {'start':(4, 41), 'end':(4, 62), 'text':'( Maeda , A. , H. Niiro , A.J. Marshall , E.A. Clark , and T. Kurosaki , unpublished data ) .'}]}]}]}, {'start':(5, 0), 'end':(5, 6), 'text':'Expression and Chromosomal Location of Bam32 .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 11), 'text':'Bam32 is clearly expressed in B , but not T lymphocytes ;'}, {'start':(6, 12), 'end':(6, 28), 'text':'however , the present data do not rule out expression in myeloid or other hematopoietic lineages .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 11), 'text':'Indeed , Bam32 is expressed at high levels in the trachea ,'}, {'start':(7, 12), 'end':(7, 22), 'text':'which contains few lymphocytes but significant numbers of dendritic cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 3), 'text':'Our preliminary results suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 4), 'end':(8, 9), 'text':'that Bam32 is expressed in monocyte'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 10), 'end':(8, 12), 'text':'derived dendritic cells'}, {'start':(8, 13), 'end':(8, 28), 'text':'( Marshall , A.J. , D. Magaletti , and E.A. Clark , unpublished data ) ,'}]}, {'start':(8, 29), 'end':(8, 39), 'text':'which could potentially account for Bam32 expression in the trachea .'}]}]}]}, {'start':(9, 0), 'end':(9, 27), 'text':'In the B lineage , Bam32 is expressed as early as the pre-B cell stage ( Marshall , A.J. , and E.A. Clark , unpublished data ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 38), 'text':'Expression in mature B cells is modulated during activation and subsequent differentiation , with a marked increase in expression during the naive to GC B cell transition , and a dramatic decrease in memory B cells ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 25), 'text':'Among human B cell lines , we observe the highest levels of Bam32 protein in the typical Burkitt \'s lymphoma lines Ramos and Daudi ( data'}, {'start':(11, 26), 'end':(11, 29), 'text':'not shown ) ,'}]}, {'start':(11, 30), 'end':(11, 38), 'text':'which share many features with GC B cells .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 3), 'text':'Finally , we find'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 4), 'end':(12, 12), 'text':'that cross linking CD40 on naive B cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 13), 'end':(12, 32), 'text':'which can turn on some phenotypic characteristics of GC B cells , leads to a rapid increase in Bam32 expression'}, {'start':(12, 33), 'end':(12, 36), 'text':'( B ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 11), 'text':'Interestingly , BCR ligation alone does not significantly affect Bam32 expression ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(13, 12), 'end':(13, 16), 'text':'and does not affect upregulation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 17), 'end':(13, 24), 'text':'when used in combination with CD40 ligation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 25), 'end':(13, 25), 'text':'suggesting'}, {'start':(13, 26), 'end':(13, 34), 'text':'that transcription of Bam32 is specifically CD40 responsive .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 5), 'text':'Together , these data strongly suggest'}, {'start':(14, 6), 'end':(14, 23), 'text':'that Bam32 expression is increased during T cell dependent B cell activation and the subsequent GC response .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 4), 'text':'It is tempting to speculate'}, {'start':(15, 5), 'end':(15, 37), 'text':'that Bam32 upregulation may be an important factor in the cross-talk between CD40 and BCR signaling pathways and and or in tuning B cell responses to antigen during affinity maturation in GCs .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 12), 'text':'The human Bam32 gene is located on chromosome 4 q25-q27 , an interval'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 13), 'end':(16, 29), 'text':'containing several other immunologically relevant genes such as IL-2 , epidermal growth factor , fibroblast growth factor'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 30), 'end':(16, 34), 'text':'2 , caspase 6 ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 35), 'end':(16, 36), 'text':'I factor'}, {'start':(16, 37), 'end':(16, 47), 'text':'( complement ) , and lymphoid enhancer binding factor 1 .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 14), 'text':'Consistent with the chromosomal assignment , the Bam32 cDNA sequence matches a sequence tagged site'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 15), 'end':(17, 22), 'text':'( STS ) on chromosome 4 ( data'}, {'start':(17, 23), 'end':(17, 26), 'text':'not shown ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 16), 'text':'Interestingly , loss of this region of chromosome 4 is observed in many Hodgkin \'s lymphomas ,'}, {'start':(18, 17), 'end':(18, 26), 'text':'which are thought to originate from GC B cells .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 11), 'text':'Given that Bam32 may negatively regulate NF-AT activation in B cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 12), 'end':(19, 17), 'text':'it will be important to determine'}, {'start':(19, 18), 'end':(19, 38), 'text':'whether defects in Bam32 expression could contribute to increased B cell proliferation and potentially malignant transformation in Hodgkin \'s lymphoma .'}]}]}]}]}]}, {'start':(20, 0), 'end':(20, 4), 'text':'Tyrosine Phosphorylation of Bam32 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 7), 'text':'Bam32 is tyrosine phosphorylated after BCR ligation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(21, 8), 'end':(21, 8), 'text':'indicating'}, {'start':(21, 9), 'end':(21, 22), 'text':'that it is a target of a kinase activated downstream of the BCR .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 6), 'text':'While Bam32 contains 10 tyrosine residues ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 7), 'end':(22, 21), 'text':'only 1 ( Y139 ) matches the general consensus motif for a tyrosine phosphorylation site'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 22), 'end':(22, 25), 'text':'in which a basic'}, {'start':(22, 26), 'end':(22, 42), 'text':'followed by an acidic amino acid are present 4-6 residues NH 2 -terminal to the tyrosine .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 7), 'text':'This tyrosine lies in an SIYESV motif ,'}, {'start':(23, 8), 'end':(23, 21), 'text':'which fits the preferred target sequence for src family kinases ( I/L-Y-D/E ) ,'}]}, {'start':(23, 22), 'end':(23, 30), 'text':'but not for syk kinase ( D-Y-E ) .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(24, 0), 'end':(24, 2), 'text':'When phosphorylated ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 3), 'end':(24, 8), 'text':'this site could form a target'}, {'start':(24, 9), 'end':(24, 17), 'text':'for binding of some SH2 domain containing proteins .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 15), 'text':'The phosphorylation of Bam32 correlates with a bandshift of 2-3 kD on our SDS-PAGE gels ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(25, 16), 'end':(25, 16), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 17), 'end':(25, 27), 'text':'that either phosphorylation at tyrosine 139 leads a stable conformational change'}, {'label':'joint', 'direction':'None', 'children':[{'start':(25, 28), 'end':(25, 52), 'text':'that retards the migration of Bam32 , ( b ) phosphorylation at tyrosine 139 is upstream of multiple phosphorylations by serine and threonine kinases ,'}, {'start':(25, 53), 'end':(25, 71), 'text':'or ( c ) Bam32 is phosphorylated on multiple tyrosines not conforming to the consensus tyrosine phosphorylation site .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 2), 'text':'We have found'}, {'start':(26, 3), 'end':(26, 19), 'text':'that phosphorylated Bam32 is poorly recognized by our mAb , consistent with a stable conformational change .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 4), 'text':'Interestingly , preliminary evidence indicates'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 5), 'end':(27, 27), 'text':'that Bam32 phosphorylation is inhibited by wortmannin pretreatment ( Niiro , H. , A.J. Marshall , and E.A. Clark , unpublished ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(27, 28), 'end':(27, 28), 'text':'suggesting'}, {'start':(27, 29), 'end':(27, 53), 'text':'that membrane recruitment of Bam32 is required for its phosphorylation and and or that activation of the kinase responsible is dependent on PI3K activity .'}]}]}]}]}]}, {'start':(28, 0), 'end':(28, 8), 'text':'Structure and Function of the Bam32 SH2 Domain .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 8), 'text':'BLAST sequence similarity searching ( available at http://www.ncbi.nlm.nih.gov/BLAST )'}, {'start':(29, 9), 'end':(29, 9), 'text':'indicated'}]}, {'start':(29, 10), 'end':(29, 46), 'text':'that the Bam32 SH2 domain is most highly related ( 30-37 % identity ) to those of the adaptor protein Nck , PLCgamma1 , PI3K p85 subunit , and the protein tyrosine phosphatases SHP-1 and SHP-2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 13), 'text':'The Bam32 SH2 domain shows the greatest overall similarity with the Nck SH2 domain'}, {'start':(30, 14), 'end':(30, 23), 'text':'( 37 % identity , 62 % similarity ) ,'}]}, {'start':(30, 24), 'end':(30, 33), 'text':'including identical residues at the betaD3 and betaD5 positions ,'}]}, {'start':(30, 34), 'end':(30, 48), 'text':'which are thought to be critical in determining specificity of binding to phosphotyrosine motifs .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 19), 'text':'Despite the similarity with the Nck SH2 domain , we have been unable to detect association of Bam32 with proteins'}, {'start':(31, 20), 'end':(31, 53), 'text':'known to associate with Nck in activated lymphocytes such as BLNK , p62 DOK , and p120 Ras-GAP ( Niiro , H. , A.J. Marshall , and E.A. Clark , unpublished data ) .'}]}, {'start':(32, 0), 'end':(32, 13), 'text':'However , we can clearly detect association of Bam32 with PLCgamma2 in vivo .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(33, 0), 'end':(33, 2), 'text':'Our results indicate'}, {'start':(33, 3), 'end':(33, 15), 'text':'that the Bam32 SH2 domain can directly bind phosphorylated PLCgamma2 in vitro ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 16), 'end':(33, 23), 'text':'however , we can not exclude the possibility'}, {'start':(33, 24), 'end':(33, 34), 'text':'that the in vivo interaction is mediated by another protein .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 1), 'text':'The finding'}, {'start':(34, 2), 'end':(34, 15), 'text':'that PLCgamma2 but not PLCgamma1 can be detected in Bam32 immunoprecipitates is intriguing ,'}]}, {'start':(34, 16), 'end':(34, 32), 'text':'and could be due to differences in the tyrosine phosphorylation motifs present in these two isoforms .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 18), 'text':'However , we did detect some binding of the Bam32 SH2 domain to tyrosine phosphorylated PLCgamma1 in vitro ,'}, {'start':(35, 19), 'end':(35, 38), 'text':'so we can not completely exclude the possibility of a low stoichiometry association between Bam32 and PLCgamma1 in vivo .'}]}, {'start':(36, 0), 'end':(36, 8), 'text':'Structure and Function of the Bam32 PH Domain .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 20), 'text':'The PH domain of Bam32 appears to be both necessary and sufficient for membrane association of Bam32 ( A ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 56), 'text':'We have observed no significant differences in the behavior of the full-length Bam32 fusion protein and the PH domain fusion protein in terms of the level of basal or induced membrane association or the sensitivity of membrane association to PI3K inhibitors ; however , the present experiments do not rule out a contribution of the SH2 domain'}, {'start':(38, 57), 'end':(38, 61), 'text':'in regulating Bam32 localization .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 26), 'text':'The PH domain of Bam32 is related ( 39 % identity ) to those of Grp1 , cytohesin-1 , and ADP ribosylation factor nucleotide binding site opener'}, {'start':(39, 27), 'end':(39, 30), 'text':'( ARNO ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 31), 'end':(39, 34), 'text':'which bind to 3-phosphoinositides'}, {'start':(39, 35), 'end':(39, 38), 'text':'generated by PI3K .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 25), 'text':'Bam32 , like Grp1 , Akt , and Btk also contains a series of conserved residues in the beta1 and beta2 strands of the PH domain'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 26), 'end':(40, 30), 'text':'that correlate with the ability'}, {'start':(40, 31), 'end':(40, 34), 'text':'to bind 3-phosphoinositides .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 13), 'text':'Thus , the structure of the Bam32 PH domain is consistent with the hypothesis'}, {'start':(41, 14), 'end':(41, 29), 'text':'that it functions as a mediator of PI3K dependent membrane association through binding of 3-phosphoinositides .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(42, 0), 'end':(42, 3), 'text':'Indeed , we find'}, {'start':(42, 4), 'end':(42, 33), 'text':'that association of Bam32 with the plasma membrane is strictly dependent on PI3K activity and an intact PI ( 3,4,5 ) P 3 -binding motif in the PH domain .'}]}, {'start':(43, 0), 'end':(43, 25), 'text':'During preparation of this manuscript , a molecule identical to Bam32 was described under the name DAPP1 , for dual adaptor for phosphotyrosine and 3-phosphoinositides .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 44), 'text':'In that report , the PH domain of DAPP1 was found to bind in vitro to the PI3K products PI ( 3,4,5 ) P 3 and PI ( 3,4 ) P 2 , consistent with our in vivo findings of PI3K dependent membrane recruitment .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 9), 'text':'Btk is another example of a B cell specific protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 10), 'end':(45, 31), 'text':'that is recruited to the plasma membrane through its PH domain in a PI3K dependent manner , through direct binding to PI'}, {'start':(45, 32), 'end':(45, 37), 'text':'( 3,4,5 ) P 3 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 12), 'text':'PH domain dependent membrane recruitment of Btk is functionally relevant because point mutations'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 13), 'end':(46, 20), 'text':'that prevent membrane recruitment block Btk activation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 21), 'end':(46, 34), 'text':'leading to defective B cell development in X linked agammaglobulinemia , and point mutations'}, {'start':(46, 35), 'end':(46, 45), 'text':'that cause constitutive membrane association lead to constitutively active Btk .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(47, 0), 'end':(47, 15), 'text':'Interestingly , direct comparison of the membrane recruitment of the Bam32 versus Btk PH domains indicated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 16), 'end':(47, 37), 'text':'that the Bam32 PH domain associates with the plasma membrane of activated B cells with higher stoichiometry than the Btk PH domain'}, {'start':(47, 38), 'end':(47, 41), 'text':'( B ) .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 14), 'text':'Since our analysis considers the ratio of localization to the membrane versus the cytoplasm ,'}, {'start':(48, 15), 'end':(48, 47), 'text':'this difference could be accounted for by a difference in their relative affinity for phosphoinositide ligands in the membrane or differences in affinity for potential protein ligands in the membrane or cytoplasm .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 22), 'text':'The Bam32 and DAPP1 PH domain was estimated to bind PI ( 3,4,5 ) P 3 with an affinity of 3 nM ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 23), 'end':(49, 34), 'text':'compared with 60 nM for 3-phosphoinositide-dependent kinase 1 ( PDK1 ) ,'}, {'start':(49, 35), 'end':(49, 45), 'text':'which was used as an internal control in that study .'}]}]}, {'start':(50, 0), 'end':(50, 23), 'text':'In contrast , the Btk PH domain was estimated to bind PI ( 3,4,5 ) P 3 with an affinity of 800 nM .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 20), 'text':'Thus , the Bam32 PH domain appears to bind PI ( 3,4,5 ) P 3 with an unusually high affinity .'}, {'start':(52, 0), 'end':(52, 7), 'text':'Role of Bam32 in B Cell Activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(53, 0), 'end':(53, 15), 'text':'The restricted expression pattern of Bam32 , together with its upregulation during B cell activation ,'}, {'start':(53, 16), 'end':(53, 30), 'text':'strongly suggests that Bam32 functions as a specific regulator of B cell signaling pathways .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 23), 'text':'Regulation of Bam32 levels during B cell differentiation ( ) could potentially modulate the stoichiometry and and or kinetics of membrane associated signaling complexes'}, {'start':(54, 24), 'end':(54, 29), 'text':'formed downstream of PI3K activation ,'}]}, {'start':(54, 30), 'end':(54, 38), 'text':'thus altering the downstream consequences of activation signals .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(55, 0), 'end':(55, 17), 'text':'Given the apparent hierarchy of affinities present in PI ( 3,4,5 ) P 3 -binding proteins ( Bam32'}, {'label':'condition', 'direction':'RightToLeft', 'children':[{'start':(55, 18), 'end':(55, 27), 'text':'-- > PDK1 -- > Btk and Akt ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 28), 'end':(55, 38), 'text':'it seems likely that Bam32 is one of the first proteins'}, {'start':(55, 39), 'end':(55, 62), 'text':'recruited during activation of PI3K and and or that Bam32 can be recruited by lower levels of PI3K activation than these other proteins .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(56, 0), 'end':(56, 7), 'text':'Consistent with this idea , our data indicate'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(56, 8), 'end':(56, 23), 'text':'that basal levels of PI ( 3,4,5 ) P 3 may be sufficient for some Bam32'}, {'start':(56, 24), 'end':(56, 29), 'text':'to associate with the plasma membrane'}]}, {'start':(56, 30), 'end':(56, 40), 'text':'so that Bam32 is at the membrane before BCR activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 3), 'text':'Our present hypothesis ,'}, {'start':(57, 4), 'end':(57, 9), 'text':'which we are currently testing ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 10), 'end':(57, 18), 'text':'is that Bam32 regulates the activity of protein kinases'}, {'start':(57, 19), 'end':(57, 34), 'text':'that are recruited later in the PI3K dependent cascade , such as Btk or Akt .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(58, 0), 'end':(58, 2), 'text':'Our results indicate'}, {'start':(58, 3), 'end':(58, 20), 'text':'that one downstream effect of increasing Bam32 levels is an inhibition of BCR induced activation of NF-AT .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 9), 'text':'Although it is difficult to conclude simply from overexpression studies'}, {'start':(59, 10), 'end':(59, 18), 'text':'what precise role Bam32 plays in BCR signaling ,'}]}, {'start':(59, 19), 'end':(59, 33), 'text':'it is clear that Bam32 can regulate the BCR signal transduction upstream of NF-AT .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 8), 'text':'Activation of NF-AT transcriptional activity in B cells ,'}, {'start':(60, 9), 'end':(60, 13), 'text':'as in T cells ,'}]}, {'start':(60, 14), 'end':(60, 22), 'text':'requires both Ca 2+ mobilization and PKC activation .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(61, 0), 'end':(61, 1), 'text':'We find'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 2), 'end':(61, 15), 'text':'that treatment of BJAB B cells with PI3K inhibitors leads to inhibition of BCR'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 16), 'end':(61, 22), 'text':'induced NF-AT activation ( D ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(61, 23), 'end':(61, 23), 'text':'indicating'}, {'start':(61, 24), 'end':(61, 38), 'text':'that the PI3K pathway recruits essential effectors upstream of NF-AT activation in B cells .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 0), 'end':(62, 28), 'text':'The requirement for PI3K in NF-AT activation may reflect , at least in part , the role of PI3K in activation of PLCgamma and subsequently Ca 2+ mobilization .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 9), 'text':'Recent work has implicated Btk as a PI3K dependent effector'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 10), 'end':(63, 17), 'text':'which is required for full activation of PLCgamma'}, {'start':(63, 18), 'end':(63, 28), 'text':'leading to influx of Ca 2+ across the plasma membrane .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(64, 0), 'end':(64, 7), 'text':'Since Bam32 binds the same phospholipid as Btk'}, {'start':(64, 8), 'end':(64, 12), 'text':'and associates with PLCgamma2 ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(64, 13), 'end':(64, 17), 'text':'it is tempting to speculate'}, {'start':(64, 18), 'end':(64, 28), 'text':'that Bam32 could regulate the activation of PLCgamma2 by Btk .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 0), 'end':(65, 7), 'text':'Overexpression of Bam32 in BJAB cells to levels'}, {'start':(65, 8), 'end':(65, 29), 'text':'that inhibit NF-AT activation by > 50 % does not lead to detectable changes in BCR induced Ca 2+ flux ( data'}]}, {'start':(65, 30), 'end':(65, 33), 'text':'not shown ) ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 34), 'end':(65, 50), 'text':'however , it remains possible that Bam32 regulates the sustained phase of the Ca 2+ response ,'}, {'start':(65, 51), 'end':(65, 63), 'text':'which is Btk dependent and critical for full activation of NF-AT-dependent transcription .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 8), 'text':'Another possibility is that Bam32 could modulate NF-AT activation'}, {'start':(66, 9), 'end':(66, 24), 'text':'by regulating Ca 2+ -independent signaling events downstream of PI3K , such as Akt activation .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 0), 'end':(67, 14), 'text':'Akt could regulate NF-AT activation through phosphorylation and inhibition of glycogen synthase kinase 3 ,'}, {'start':(67, 15), 'end':(67, 26), 'text':'whose activity opposes calcineurin dependent translocation of NF-AT to the nucleus .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 20), 'text':'Expression of constitutively active Akt enhances TCR induced NF-AT activation , consistent with a role for Akt in NF-AT activation .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 16), 'text':'The PI3K pathway has been shown to be essential for B cell activation and differentiation in studies'}, {'start':(69, 17), 'end':(69, 38), 'text':'examining the effect of PI3K inhibitors on B cell responses in vitro and the effect of PI3K p85alpha deficiency in mice .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 0), 'end':(70, 14), 'text':'Furthermore , the PI3K pathway is subject to opposing regulation by the CD19 coreceptor ,'}, {'start':(70, 15), 'end':(70, 30), 'text':'which recruits PI3K to the antigen receptor complex , and the inhibitory Fc receptor FcgammaRII ,'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(70, 31), 'end':(70, 36), 'text':'which specifically antagonizes the PI3K pathway'}, {'start':(70, 37), 'end':(70, 43), 'text':'by recruiting the inositol phosphatase SHIP .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(71, 0), 'end':(71, 15), 'text':'Bam32 is clearly a novel component of this critical PI3K activation pathway in B lymphocytes ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(71, 16), 'end':(71, 19), 'text':'and our results suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 20), 'end':(71, 27), 'text':'that it may specifically regulate PI3K dependent effectors'}, {'start':(71, 28), 'end':(71, 33), 'text':'involved in activation of NF-AT .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 16), 'text':'Modulation of BCR induced NF-AT activation by Bam32 could have important functional consequences for B cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 17), 'end':(72, 32), 'text':'since B cells from NF-ATc-deficient mice have diminished proliferative responses to a variety of stimuli ,'}, {'start':(72, 33), 'end':(72, 38), 'text':'including BCR or CD40 ligation .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(73, 0), 'end':(73, 9), 'text':'In contrast , B cells from NF-ATp-deficient mice are hyperproliferative'}, {'start':(73, 10), 'end':(73, 22), 'text':'and B cells from NF-AT4-deficient mice show an activated phenotype in vivo .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(74, 0), 'end':(74, 1), 'text':'We speculate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 2), 'end':(74, 28), 'text':'that upregulation of Bam32 during the GC response may lead to qualitative changes in BCR signaling to the nucleus necessary for the exquisitely sensitive process of selection'}, {'start':(74, 29), 'end':(74, 34), 'text':'based on affinity for antigen .'}]}]}]}]}]}]}]}
90	169	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 6), 'text':'Cloning of Bam32 , A Novel GC'}, {'start':(1, 7), 'end':(1, 10), 'text':'associated Signaling Adaptor .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 2), 'text':'To identify genes'}, {'start':(2, 3), 'end':(2, 6), 'text':'expressed in GCs ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 7), 'end':(2, 12), 'text':'we carried out an SSH experiment'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 13), 'end':(2, 25), 'text':'using an enriched preparation of human FDCs as a source of tester cDNA'}, {'start':(2, 26), 'end':(2, 32), 'text':'( see Materials and Methods ) .'}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 2), 'text':'PCR analysis indicated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 3), 'end':(3, 9), 'text':'that our tester cDNA included both transcripts'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 10), 'end':(3, 14), 'text':'derived from FDCs and transcripts'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 15), 'end':(3, 19), 'text':'derived from adhering B cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 20), 'end':(3, 21), 'text':'( data'}, {'start':(3, 22), 'end':(3, 25), 'text':'not shown ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 5), 'text':'One of the differentially expressed clones'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 6), 'end':(4, 20), 'text':'isolated from this subtraction experiment contained a partial coding sequence for a novel SH2 domain'}, {'start':(4, 21), 'end':(4, 23), 'text':'containing protein .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 2), 'text':'Several cDNA clones'}, {'start':(5, 3), 'end':(5, 13), 'text':'containing the entire protein coding sequence for this gene were obtained'}]}, {'start':(5, 14), 'end':(5, 22), 'text':'by screening a human lymph node cDNA library .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 6), 'text':'The cDNA sequence predicts a 32-kD protein'}, {'label':'contrast', 'direction':'None', 'children':[{'start':(6, 7), 'end':(6, 19), 'text':'containing an NH 2 -terminal SH2 domain and a COOH-terminal PH domain ,'}, {'start':(6, 20), 'end':(6, 29), 'text':'but lacking any known catalytic domains ( A ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 5), 'text':'The sequence contains 10 tyrosines ,'}, {'start':(7, 6), 'end':(7, 18), 'text':'1 of which matches the consensus motif for a tyrosine phosphorylation site .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 11), 'text':'Thus , this molecule represents a new member of the adaptor class'}, {'start':(8, 12), 'end':(8, 15), 'text':'of signaling molecules .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 11), 'text':'Based on this structure and the restricted expression pattern of this gene'}, {'start':(9, 12), 'end':(9, 16), 'text':'( see below ) ,'}]}, {'start':(9, 17), 'end':(9, 31), 'text':'we have designated this molecule Bam32 for B lymphocyte adaptor molecule of 32 kD .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 10), 'text':'The murine Bam32 homologue was isolated by low stringency PCR ,'}, {'start':(10, 11), 'end':(10, 17), 'text':'followed by RACE ( A ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 14), 'text':'Murine Bam32 shares 96.7 % sequence identity with the human protein within the central portion'}, {'start':(11, 15), 'end':(11, 21), 'text':'containing the SH2 and PH domains .'}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 17), 'text':'In contrast , the NH 2 -terminal region is less well conserved ( 76.5 % identity ) ,'}, {'start':(12, 18), 'end':(12, 31), 'text':'while the COOH-terminal 20 amino acids are completely different than our human clones .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 11), 'text':'However , the expressed sequence tag ( EST ) database contains an'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 12), 'end':(13, 17), 'text':'alternatively spliced human Bam32 cDNA sequence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 18), 'end':(13, 22), 'text':'that encodes a COOH-terminal sequence'}, {'start':(13, 23), 'end':(13, 34), 'text':'corresponding to our mouse Bam32 clone ( 82.6 % identity ) .'}]}]}]}, {'start':(14, 0), 'end':(14, 19), 'text':'We designate the two human splice forms hbam1 and hbam2 and the corresponding murine sequence mbam1 ( A ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 14), 'text':'The chromosomal location of the human Bam32 gene was determined by fluorescent in situ hybridization'}, {'start':(15, 15), 'end':(15, 23), 'text':'( FISH ) on banded human metaphase chromosomes .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 4), 'text':'In the majority of cells'}, {'start':(16, 5), 'end':(16, 11), 'text':'examined ( 44 and 67 ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 12), 'end':(16, 24), 'text':'clear signals were observed on both chromatids of chromosome 4 at band q25-q27'}, {'start':(16, 25), 'end':(16, 28), 'text':'( B ) .'}]}]}]}]}, {'start':(17, 0), 'end':(17, 14), 'text':'Bam32 Is Expressed by B Lymphocytes , but Not T Cells or Nonhematopoietic Cells .'}]}, {'start':(18, 0), 'end':(18, 15), 'text':'Expression of Bam32 in human tissues was determined by Northern blot analysis ( A ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 10), 'text':'Our Bam32 cDNA probe detects both a predominant 2.9-kb transcript ,'}, {'start':(19, 11), 'end':(19, 27), 'text':'corresponding in size to our largest cDNA clones , and a much less abundant 4.4-kb transcript .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 7), 'text':'Bam32 transcripts are detected in all hematopoietic tissues'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 8), 'end':(20, 29), 'text':'tested ( bone marrow , spleen , lymph node , and peripheral blood leukocytes ) with the exception of the thymus ,'}, {'start':(20, 30), 'end':(20, 36), 'text':'which shows little or no expression .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 16), 'text':'Bam32 expression was also observed in trachea and placenta , but not in 14 other nonlymphoid tissues'}, {'start':(21, 17), 'end':(21, 28), 'text':'including brain , heart , kidney , liver and skeletal muscle ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(21, 29), 'end':(21, 29), 'text':'indicating'}, {'start':(21, 30), 'end':(21, 41), 'text':'that expression is largely confined to cells of the immune system .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 10), 'text':'Consistent with the restricted tissue distribution pattern , RT-PCR analyses indicated'}, {'start':(22, 11), 'end':(22, 40), 'text':'that Bam32 is expressed in all B cell lines examined , but not in T cell , epithelial cell , fibroblast , or myelocytic leukemia lines ( B ) .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(23, 0), 'end':(23, 2), 'text':'As expected ,'}, {'start':(23, 3), 'end':(23, 24), 'text':'Bam32 transcripts were detected in the sort enriched tonsillar FDC tester RNA , but not in the fibroblast pool driver RNA .'}]}]}]}]}]}]}, {'start':(24, 0), 'end':(24, 8), 'text':'Bam32 Expression Is Increased upon B Cell Activation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 6), 'text':'Since Bam32 was isolated as a GC'}, {'start':(25, 7), 'end':(25, 9), 'text':'associated gene ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 10), 'end':(25, 13), 'text':'it was of interest'}, {'start':(25, 14), 'end':(25, 27), 'text':'to compare the expression of Bam32 at different stages of B cell differentiation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 24), 'text':'Therefore , we fractionated human tonsillar B cells into naive , GC , and memory subsets on the basis of CD38 and IgD expression .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 8), 'text':'While Bam32 transcripts were detected in all fractions ,'}, {'start':(27, 9), 'end':(27, 23), 'text':'GC B cells expressed fourfold higher levels than naive B cells ( A ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 18), 'text':'Furthermore , the memory B cell fraction expressed 15-fold lower levels of Bam32 transcripts than GC B cells .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 2), 'text':'These results suggest'}, {'start':(29, 3), 'end':(29, 15), 'text':'that Bam32 expression levels are modulated during B cell activation and differentiation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 5), 'text':'To further investigate the activation signals'}, {'start':(30, 6), 'end':(30, 11), 'text':'that might regulate Bam32 expression ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 12), 'end':(30, 17), 'text':'resting B cells were stimulated in'}, {'start':(30, 18), 'end':(30, 27), 'text':'vitro with CD40 antibodies and Bam32 expression was determined .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 10), 'text':'CD40 ligation led to a 5-10-fold increase in Bam32 expression ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 11), 'end':(31, 17), 'text':'whereas BCR ligation had no significant effect'}, {'start':(31, 18), 'end':(31, 21), 'text':'( B ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 4), 'text':'Together , these results suggest'}, {'start':(32, 5), 'end':(32, 16), 'text':'that Bam32 expression is specifically increased during T cell dependent activation ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 17), 'end':(32, 27), 'text':'is maintained at high levels during the subsequent GC response ,'}, {'start':(32, 28), 'end':(32, 37), 'text':'and then decreases upon differentiation to memory B cells .'}]}]}]}]}, {'start':(33, 0), 'end':(33, 15), 'text':'Bam32 Is Phosphorylated on Tyrosine and Associates with PLCgamma2 after BCR Ligation or Pervanadate Stimulation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(34, 0), 'end':(34, 13), 'text':'To determine whether Bam32 associates with tyrosine phosphorylated proteins after B cell activation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 14), 'end':(34, 27), 'text':'Bam32 was immunoprecipitated from lysates of resting or activated B cells and the precipitates'}, {'label':'joint', 'direction':'None', 'children':[{'start':(34, 28), 'end':(34, 31), 'text':'were run on SDS-PAGE'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 32), 'end':(34, 38), 'text':'and blotted with biotinylated phosphotyrosine specific mAb'}, {'start':(34, 39), 'end':(34, 45), 'text':'followed by streptavidin-peroxidase ( A ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 4), 'text':'Two predominant tyrosine phosphorylated proteins'}, {'start':(35, 5), 'end':(35, 26), 'text':'running at ~ 140 and 35 and 36 kD were detected in Bam32 immunoprecipitates from BCR- or pervanadate stimulated Ramos cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'As expected ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 3), 'end':(36, 16), 'text':'neither of these bands was observed in immunoprecipitates from pervanadate stimulated Jurkat cells ,'}, {'start':(36, 17), 'end':(36, 22), 'text':'which do not express Bam32 .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 6), 'text':'We found no evidence for a phosphoprotein'}, {'start':(37, 7), 'end':(37, 11), 'text':'running at 32 kD ;'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(37, 12), 'end':(37, 13), 'text':'however ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(37, 14), 'end':(37, 23), 'text':'when Bam32 immunoprecipitates were blotted with polyclonal Bam32 antibodies ,'}, {'start':(37, 24), 'end':(37, 45), 'text':'an additional band of ~ 35 and 36 kD was detectable after BCR or pervanadate activation ( A , bottom ) .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(38, 0), 'end':(38, 7), 'text':'This band was not present in unstimulated cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 8), 'end':(38, 16), 'text':'and comigrated with the 35 and 36 kD band'}, {'start':(38, 17), 'end':(38, 21), 'text':'detected by antiphosphotyrosine blotting ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(38, 22), 'end':(38, 22), 'text':'indicating'}, {'start':(38, 23), 'end':(38, 29), 'text':'that it represents tyrosine phosphorylated Bam32 .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 12), 'text':'Consistent with this conclusion , myc epitope tagged Bam32 also underwent a bandshift'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 13), 'end':(39, 19), 'text':'and was tyrosine phosphorylated after pervanadate stimulation'}, {'start':(39, 20), 'end':(39, 23), 'text':'( B ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 10), 'text':'Western blot analyses identified the 140-kD associated protein as PLCgamma2 ,'}, {'start':(40, 11), 'end':(40, 25), 'text':'whereas neither PLCgamma1 nor BLNK could be detected in Bam32 immunoprecipitates ( A ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(41, 0), 'end':(41, 11), 'text':'Although we can detect some constitutive association of Bam32 with PLCgamma2 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 12), 'end':(41, 17), 'text':'association is substantially increased after activation'}, {'start':(41, 18), 'end':(41, 21), 'text':'( B ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 12), 'text':'A Bam32 SH2 domain fusion protein bound in vitro to tyrosine phosphorylated PLCgamma2'}, {'start':(42, 13), 'end':(42, 34), 'text':'immobilized on a nitrocellulose membrane , but not to CD22 ( C ) , syk , or SH2 domain containing inositol 5-phosphatase'}]}, {'start':(42, 35), 'end':(42, 43), 'text':'( SHIP ) ( data not shown ) ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(42, 44), 'end':(42, 44), 'text':'suggesting'}, {'label':'joint', 'direction':'None', 'children':[{'start':(42, 45), 'end':(42, 50), 'text':'that the Bam32-PLCgamma2 interaction is direct'}, {'start':(42, 51), 'end':(42, 57), 'text':'and mediated by the SH2 domain .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 15), 'text':'Weak binding of the Bam32 SH2 fusion protein to PLCgamma1 was also detected under these conditions'}, {'start':(43, 16), 'end':(43, 24), 'text':'( C , and data not shown ) .'}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 2), 'text':'These results indicate'}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 3), 'end':(44, 19), 'text':'that Bam32 can interact with tyrosine phosphorylated signaling molecules after B cell activation through its SH2 domain'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(44, 20), 'end':(44, 24), 'text':'and may function in part'}, {'start':(44, 25), 'end':(44, 35), 'text':'by regulating the activity and and or location of PLCgamma2 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 9), 'text':'Bam32 Is Recruited to the Plasma Membrane after BCR Cross'}, {'start':(45, 10), 'end':(45, 15), 'text':'Linking Via Its PH Domain .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 1), 'text':'We hypothesized'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 2), 'end':(46, 17), 'text':'that Bam32 may associate with the plasma membrane through binding of its PH domain to phosphoinositides'}, {'start':(46, 18), 'end':(46, 21), 'text':'generated by PI3K ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 22), 'end':(46, 32), 'text':'as observed with a subset of PH domain containing proteins ,'}, {'start':(46, 33), 'end':(46, 38), 'text':'including Btk in B cells .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(47, 0), 'end':(47, 13), 'text':'To determine the subcellular localization of Bam32 before and after BCR cross linking ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 14), 'end':(47, 20), 'text':'we transfected BJAB B cells with constructs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 21), 'end':(47, 24), 'text':'encoding EGFP or EGFP'}, {'label':'joint', 'direction':'None', 'children':[{'start':(47, 25), 'end':(47, 27), 'text':'fused to Bam32'}, {'start':(47, 28), 'end':(47, 41), 'text':'and examined the subcellular localization of the fusion proteins by confocal fluorescence microscopy .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 11), 'text':'While the native EGFP showed only diffuse cytoplasmic and nuclear signal ,'}, {'start':(48, 12), 'end':(48, 28), 'text':'a proportion of the EGFP-Bam32 fusion protein was associated with the plasma membrane ( A ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 11), 'text':'Membrane localization of Bam32-EGFP was increased by approximately threefold after BCR cross'}, {'start':(49, 12), 'end':(49, 21), 'text':'linking ( A , and data not shown ) .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(50, 0), 'end':(50, 18), 'text':'To determine which domains of Bam32 are required for membrane association , the NH 2 -terminal half of Bam32'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 19), 'end':(50, 26), 'text':'containing the SH2 domain or the COOH-terminal half'}, {'start':(50, 27), 'end':(50, 39), 'text':'containing the PH domain was independently expressed as a fusion with EGFP .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(51, 0), 'end':(51, 1), 'text':'We found'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(51, 2), 'end':(51, 11), 'text':'that the SH2 domain fusion localized to the cytoplasm ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 12), 'end':(51, 24), 'text':'whereas the PH domain fusion showed a clear association with the plasma membrane'}, {'start':(51, 25), 'end':(51, 33), 'text':'that increased after BCR ligation ( A ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 18), 'text':'The full-length Bam32 fusion and the PH domain fusion show similar levels of basal and induced membrane association ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(52, 19), 'end':(52, 19), 'text':'indicating'}, {'start':(52, 20), 'end':(52, 32), 'text':'that the PH domain is both necessary and sufficient for membrane recruitment .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 13), 'text':'The surprisingly high basal level of Bam32 membrane association in BJAB B cells ,'}, {'start':(53, 14), 'end':(53, 27), 'text':'which was not observed with the Btk PH domain in NIH 3T3 cells ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 28), 'end':(53, 49), 'text':'prompted us to compare the relative levels and kinetics of membrane association of the Bam32 and Btk PH domains after BCR ligation'}, {'start':(53, 50), 'end':(53, 53), 'text':'( B ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(54, 0), 'end':(54, 18), 'text':'By quantifying relative fluorescence levels in the plasma membrane versus the cytoplasm at various time points after stimulation ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(54, 19), 'end':(54, 20), 'text':'we found'}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(54, 21), 'end':(54, 37), 'text':'that membrane recruitment of the Bam32 PH domain was evident within 1 min of BCR stimulation ,'}, {'start':(54, 38), 'end':(54, 43), 'text':'peaks at ~ 5 min ,'}]}, {'start':(54, 44), 'end':(54, 52), 'text':'and then slowly declines back to basal levels .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(55, 0), 'end':(55, 36), 'text':'The Btk PH domain was recruited with similar kinetics ; however , a significantly lower proportion of the fusion protein is present at the plasma membrane ( relative to the cytoplasm ) at each time point ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 37), 'end':(55, 45), 'text':'and membrane association was not observed in unstimulated cells'}, {'start':(55, 46), 'end':(55, 49), 'text':'( B ) .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 16), 'text':'Unlike Bam32 , a significant proportion of the Btk PH domain fusion protein localized to the nucleus'}, {'start':(56, 17), 'end':(56, 20), 'text':'as observed previously .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(57, 0), 'end':(57, 2), 'text':'These results suggest'}, {'label':'joint', 'direction':'None', 'children':[{'start':(57, 3), 'end':(57, 20), 'text':'that the Bam32 PH domain is rapidly and quantitatively recruited to the plasma membrane after BCR ligation ,'}, {'start':(57, 21), 'end':(57, 39), 'text':'and may have a higher selectively for binding to the activated plasma membrane than the Btk PH domain .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 26), 'text':'Recruitment of the Bam32 PH Domain to the Plasma Membrane Is Dependent on PI3K Activity and an Intact PI ( 3,4,5 ) P 3 -binding Motif .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(59, 0), 'end':(59, 1), 'text':'We examined'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(59, 2), 'end':(59, 14), 'text':'whether membrane association of the Bam32 PH domain was dependent on PI3K activity'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 15), 'end':(59, 17), 'text':'by preincubating cells'}, {'start':(59, 18), 'end':(59, 43), 'text':'expressing EGFP-Bam32 or EGFP-Bam32 PH domain fusion proteins with two structurally unrelated PI3K inhibitors , wortmannin or LY294002 , before BCR ligation ( A ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 9), 'text':'These inhibitors blocked membrane association of both fusion proteins ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(60, 10), 'end':(60, 10), 'text':'demonstrating'}, {'start':(60, 11), 'end':(60, 29), 'text':'that membrane association of both the PH domain and Bam32 as a whole is dependent on PI3K activity .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(61, 0), 'end':(61, 10), 'text':'Alignment of the Bam32 PH domain with other PH domains reveals'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 11), 'end':(61, 24), 'text':'that Bam32 contains a series of amino acids in the beta2 and beta3 strands'}, {'start':(61, 25), 'end':(61, 38), 'text':'that are conserved among PI ( 3,4,5 ) P 3 -binding PH domains ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 39), 'end':(61, 41), 'text':'including the arginine'}, {'start':(61, 42), 'end':(61, 47), 'text':'corresponding to R28 in Btk ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 48), 'end':(61, 53), 'text':'which is mutated in human X'}, {'start':(61, 54), 'end':(61, 60), 'text':'linked agammaglobulinemia patients and Xid mice ,'}]}]}, {'start':(61, 61), 'end':(61, 75), 'text':'and which forms part of the PI ( 3,4,5 ) P 3 -binding pocket .'}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 0), 'end':(62, 17), 'text':'To test whether membrane association of the Bam32 PH domain requires the conserved arginine in this putative PI'}, {'start':(62, 18), 'end':(62, 24), 'text':'( 3,4,5 ) 3 -binding pocket ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 25), 'end':(62, 30), 'text':'we generated a construct encoding EGFP'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 31), 'end':(62, 36), 'text':'fused to the Bam32 PH domain'}, {'start':(62, 37), 'end':(62, 41), 'text':'bearing an R184C mutation .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 10), 'text':'The R184C mutation completely abrogated membrane association ( B ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(63, 11), 'end':(63, 15), 'text':'providing support for the hypothesis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 16), 'end':(63, 31), 'text':'that the PI3K dependent association of the Bam32 PH domain occurs through direct binding to PI'}, {'start':(63, 32), 'end':(63, 36), 'text':'( 3,4,5 ) 3 .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(64, 0), 'end':(64, 1), 'text':'Interestingly ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(64, 2), 'end':(64, 9), 'text':'when aligned with the Btk PH domain ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 10), 'end':(64, 23), 'text':'the Bam32 PH domain also contains an amino acid substitution in the beta3 strand'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 24), 'end':(64, 29), 'text':'found in a gain-of-function Btk mutant'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 30), 'end':(64, 34), 'text':'that shows constitutive membrane association'}, {'start':(64, 35), 'end':(64, 43), 'text':'( E41K ; references 14 , 38 ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(65, 0), 'end':(65, 11), 'text':'To examine the role of this residue in Bam32 membrane association ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(65, 12), 'end':(65, 18), 'text':'we generated a K197E mutant PH domain'}, {'start':(65, 19), 'end':(65, 26), 'text':'and examined membrane association ( B ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 10), 'text':'Surprisingly , the K197E mutation also completely disrupted membrane association ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(66, 11), 'end':(66, 11), 'text':'suggesting'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 12), 'end':(66, 15), 'text':'that this residue ,'}, {'start':(66, 16), 'end':(66, 25), 'text':'which is not conserved among phosphoinositide binding PH domains ,'}]}, {'start':(66, 26), 'end':(66, 38), 'text':'has a critical role in phosphoinositide binding of the Bam32 PH domain .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 0), 'end':(67, 20), 'text':'We have confirmed the effect of the R28C and K41E mutations on membrane association by immunofluorescence staining of full-length Bam32 proteins'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 21), 'end':(67, 24), 'text':'expressed in BJAB cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 25), 'end':(67, 26), 'text':'( data'}, {'start':(67, 27), 'end':(67, 30), 'text':'not shown ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(68, 0), 'end':(68, 6), 'text':'Together , the results in and suggest'}, {'start':(68, 7), 'end':(68, 40), 'text':'that , after BCR ligation , Bam32 is recruited to the plasma membrane at sites of PI3K activation through binding to PI ( 3,4,5 ) P 3 in a manner analogous to Btk .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 3), 'text':'Bam32 Can Modulate BCR'}, {'start':(69, 4), 'end':(69, 7), 'text':'induced Transcriptional Activation .'}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(70, 0), 'end':(70, 18), 'text':'To determine whether the presence of Bam32 in membrane associated signaling complexes can regulate signaling through the BCR ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 19), 'end':(70, 22), 'text':'we assessed the effect'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 23), 'end':(70, 30), 'text':'of overexpressing wild-type or mutant Bam32 proteins ,'}, {'start':(70, 31), 'end':(70, 41), 'text':'using downstream transcriptional activation as a readout for BCR signaling .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 12), 'text':'Bam32 expression constructs were cotransfected into BJAB cells with a luciferase reporter construct'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 13), 'end':(71, 17), 'text':'that allows measurement of transcription'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 18), 'end':(71, 26), 'text':'mediated by NF-AT , a family of transcription factors'}, {'start':(71, 27), 'end':(71, 39), 'text':'that are important regulators of both B and T cell activation responses .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 20), 'text':'Strikingly , expression of wild-type Bam32 inhibited BCR induced activation of NF-AT in a dose dependent manner ( A ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(72, 21), 'end':(72, 21), 'text':'suggesting'}, {'start':(72, 22), 'end':(72, 40), 'text':'that modulation of Bam32 dose during B cell differentiation ( ) could affect the outcome of BCR ligation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(73, 0), 'end':(73, 14), 'text':'The observed decrease in NF-AT activation is due to modulation of BCR signaling pathways ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 15), 'end':(73, 30), 'text':'since Bam32 expression level had no significant affect on cell viabilities or levels of NF-AT activation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 31), 'end':(73, 38), 'text':'induced by phorbol ester and ionomycin ( data'}, {'start':(73, 39), 'end':(73, 42), 'text':'not shown ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 0), 'end':(74, 9), 'text':'Deletion of the PH domain abrogated the ability of Bam32'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 10), 'end':(74, 12), 'text':'to inhibit BCR'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 13), 'end':(74, 16), 'text':'induced NF-AT activation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 17), 'end':(74, 35), 'text':'whereas mutation of the invariant arginine of the SH2 domain to lysine ( R61K ) had no significant effect'}, {'start':(74, 36), 'end':(74, 39), 'text':'( B ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 0), 'end':(75, 0), 'text':'Cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 1), 'end':(75, 3), 'text':'expressing full-length Bam32'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(75, 4), 'end':(75, 18), 'text':'containing the R184C or K197E mutations showed similar or slightly increased BCR induced NF-AT activation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 19), 'end':(75, 21), 'text':'compared with controls'}, {'start':(75, 22), 'end':(75, 25), 'text':'( C ) ,'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(75, 26), 'end':(75, 26), 'text':'indicating'}, {'start':(75, 27), 'end':(75, 44), 'text':'that PI ( 3,4,5 ) 3 -mediated membrane recruitment of Bam32 is required for the inhibitory effect .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(76, 0), 'end':(76, 22), 'text':'Since Bam32 functions downstream of PI3K , and the role of PI3K in NF-AT activation has not been examined in B cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 23), 'end':(76, 38), 'text':'we determined the effect of PI3K inhibitors on BCR induced activation of NF-AT in BJAB cells'}, {'start':(76, 39), 'end':(76, 42), 'text':'( D ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 13), 'text':'Both wortmannin and Ly294002 inhibited BCR induced NF-AT activation in a dose dependent manner'}, {'start':(77, 14), 'end':(77, 17), 'text':'( D ) ,'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(77, 18), 'end':(77, 30), 'text':'and this inhibition was not due to nonspecific toxicity of the inhibitors ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 31), 'end':(77, 43), 'text':'since PdBu plus ionomycin induced NF-AT activation was not significantly affected ( data'}, {'start':(77, 44), 'end':(77, 47), 'text':'not shown ) .'}]}]}]}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(78, 0), 'end':(78, 2), 'text':'This result indicates'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(78, 3), 'end':(78, 8), 'text':'that BCR induced NF-AT activation requires'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(78, 9), 'end':(78, 13), 'text':'effectors downstream of PI3K ,'}, {'start':(78, 14), 'end':(78, 24), 'text':'as was previously found for TCR induced activation of NF-AT .'}]}]}]}]}]}]}]}]}
30	90	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and Methods'}, {'start':(1, 0), 'end':(1, 5), 'text':'Isolation of the Bam32 cDNA .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 7), 'text':'Enriched FDC populations were obtained from human tonsils'}, {'start':(2, 8), 'end':(2, 16), 'text':'according to the method of Liu et al. .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 15), 'text':'Cells ( 10 6 ) were pooled from three preparations , total RNA was isolated ,'}, {'start':(3, 16), 'end':(3, 39), 'text':'and double stranded cDNA was produced using the switching mechanism at RNA termini ( SMART ) PCR cDNA synthesis method ( Clontech ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 5), 'text':'PCR analysis of the resulting cDNA'}, {'start':(4, 6), 'end':(4, 7), 'text':'using primers'}]}, {'start':(4, 8), 'end':(4, 18), 'text':'that can distinguish FDC and B cell isoforms of CD21 indicated'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 19), 'end':(4, 27), 'text':'that both isoforms were present in approximately equal proportions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 28), 'end':(4, 29), 'text':'( data'}, {'start':(4, 30), 'end':(4, 33), 'text':'not shown ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 11), 'text':'A double stranded driver cDNA was concomitantly produced by the same method'}, {'start':(5, 12), 'end':(5, 31), 'text':'using an equal mixture of RNA from the fibroblast cell lines HFF and 122 and the epithelial line HeLa .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 18), 'text':'A suppression subtractive hybridization ( SSH ) PCR subtraction procedure was carried out according to the manufacturer \'s protocol'}, {'start':(6, 19), 'end':(6, 25), 'text':'( PCR Select ; Clontech ) ,'}]}, {'start':(6, 26), 'end':(6, 41), 'text':'using the FDC cDNA as tester and the fibroblast and epithelial cell cDNA as driver .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 14), 'text':'The pool of differentially expressed gene fragments generated was then cloned into the pCRII vector'}, {'start':(7, 15), 'end':(7, 18), 'text':'( Invitrogen ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 19), 'end':(7, 29), 'text':'and 60 clones were randomly picked and screened for differential expression'}, {'start':(7, 30), 'end':(7, 36), 'text':'using tester and driver cDNA probes .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 7), 'text':'Differentially expressed clones were sequenced by dye-terminator sequencing'}, {'start':(8, 8), 'end':(8, 12), 'text':'( PE Biosystems ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 8), 'text':'The Bam32 SSH fragment was used as a probe'}, {'start':(9, 9), 'end':(9, 17), 'text':'to screen a human lymph node cDNA library ,'}]}, {'start':(9, 18), 'end':(9, 26), 'text':'and several positive clones were obtained and sequenced .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 19), 'text':'A fragment of the murine Bam32 cDNA was obtained by low stringency reverse transcription ( RT ) - PCR ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 20), 'end':(10, 32), 'text':'and then the entire cDNA was obtained using rapid amplification of cDNA ends'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 33), 'end':(10, 41), 'text':'( RACE ) with an adaptor ligated cDNA template'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 42), 'end':(10, 47), 'text':'derived from Balb and c spleen'}, {'start':(10, 48), 'end':(10, 51), 'text':'( Clontech ) .'}]}]}]}]}]}]}]}]}]}]}, {'start':(11, 0), 'end':(11, 4), 'text':'Fluorescence In Situ Hybridization .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 0), 'text':'Plasmids'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 1), 'end':(12, 18), 'text':'containing 5 \' and 3 \' fragments of the Bam32 cDNA were labeled with biotin-11-dATP by nick translation'}, {'start':(12, 19), 'end':(12, 23), 'text':'( GIBCO BRL ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 29), 'text':'Metaphase chromosome preparations from lymphocytes of a human male were obtained using 0.075 M KCl as a hypotonic buffer and methanol and acetic acid ( 3:1 vol and vol )'}, {'start':(13, 30), 'end':(13, 33), 'text':'as a fixative .'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 3), 'text':'Hybridization was carried out'}, {'start':(14, 4), 'end':(14, 7), 'text':'as described previously .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 3), 'text':'The chromosomes were banded'}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 4), 'end':(15, 8), 'text':'using Hoechst 33258-actinomycin D staining'}, {'start':(15, 9), 'end':(15, 14), 'text':'and counterstained with propidium iodide .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 9), 'text':'The chromosomes and hybridization signals were visualized by fluorescence microscopy'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 10), 'end':(16, 14), 'text':'using a dual bandpass filter'}, {'start':(16, 15), 'end':(16, 18), 'text':'( Omega ) .'}]}]}, {'start':(17, 0), 'end':(17, 6), 'text':'Northern Blot and RT-PCR Expression Analysis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 2), 'text':'A 32 P'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 3), 'end':(18, 22), 'text':'labeled Bam32 cDNA probe was hybridized to human multiple tissue Northern blots ( Clontech ) and to a Northern blot'}, {'start':(18, 23), 'end':(18, 34), 'text':'containing 2 mug of poly A + RNA from human tonsils ,'}]}]}, {'start':(18, 35), 'end':(18, 41), 'text':'according to the manufacturer \'s protocol .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 15), 'text':'For RT-PCR analysis , 2 mug of total RNA from the indicated cell lines was reverse'}, {'start':(19, 16), 'end':(19, 26), 'text':'transcribed using Superscript II reverse transcriptase ( GIBCO BRL ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 14), 'text':'1 and 10 of the resulting cDNA was subjected to PCR amplification for 30 cycles'}, {'start':(20, 15), 'end':(20, 33), 'text':'using Bam32 specific primers TGTCTCACAGAGCGAGAAGGTGTCAGG and GAACCATCAGAGTGCCTGTCTCGCTTCC or glyceraldehyde-3-phosphate dehydrogenase ( G3PDH ) control primers TGAAGGTCGGAGTCAACGGATTTGGT and CATGTGGGCCATGAGGTCCACCAC .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 9), 'text':'The resulting PCR products were run on agarose gels ,'}, {'start':(21, 10), 'end':(21, 12), 'text':'Southern blotted ,'}]}, {'start':(21, 13), 'end':(21, 18), 'text':'and hybridized with oligonucleotide probes :'}]}, {'start':(21, 19), 'end':(21, 28), 'text':'CTCTACCTCTGTGAAGGGCGCGAATG ( Bam32 ) and TGGGCGCCTGGTCACCAGGGCTGCTT ( G3PDH ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 15), 'text':'For analysis of Bam32 expression in primary B cell subsets , tonsillar B cells were prepared'}, {'start':(22, 16), 'end':(22, 18), 'text':'as described ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 19), 'end':(22, 21), 'text':'stained with FITC'}, {'start':(22, 22), 'end':(22, 35), 'text':'labeled anti-IgD ( mAb deltaSTA4-1 ) and PE labeled anti-CD38 ( Immunotech ) ,'}]}]}, {'start':(22, 36), 'end':(22, 42), 'text':'and sorted into IgD + CD38 -'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 43), 'end':(22, 63), 'text':'( naive ) , IgD - CD38 + ( GC ) , and IgD - CD38 + ( memory ) fractions'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 64), 'end':(22, 71), 'text':'using a FACStar PLUS ( TM ) instrument'}, {'start':(22, 72), 'end':(22, 76), 'text':'( Becton Dickinson ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 22), 'text':'For in vitro stimulation experiments , naive ( high density ) B cells were prepared by Percoll fractionation of tonsillar B cells ,'}, {'start':(23, 23), 'end':(23, 25), 'text':'as described .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(24, 0), 'end':(24, 12), 'text':'Cells were stimulated with 2 mug and ml anti-CD40 ( mAb G28-5 )'}, {'start':(24, 13), 'end':(24, 19), 'text':'and harvested at the indicated time .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 13), 'text':'The indicated dilution of first-strand cDNA was used for PCR amplification as above .'}, {'start':(26, 0), 'end':(26, 4), 'text':'Expression Constructs and Antibodies .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 4), 'text':'Eukaryotic expression vectors were generated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 5), 'end':(27, 24), 'text':'by inserting the full-length coding sequence or sequence encoding amino acids 1-142 ( DeltaPH COOH-terminal truncation mutant ) into pcDNA3'}, {'start':(27, 25), 'end':(27, 28), 'text':'( Invitrogen ) .'}]}]}, {'start':(28, 0), 'end':(28, 28), 'text':'Myc tagged Bam32 expression vector was generated by inserting the Bam32 coding sequence into pcDNA3 .1 myc and hisA ( Invitrogen ) in frame with the myc tag .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 0), 'text':'Constructs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 1), 'end':(29, 2), 'text':'encoding Bam32'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 3), 'end':(29, 6), 'text':'enhanced green fluorescent protein'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(29, 7), 'end':(29, 13), 'text':'( EGFP ) fusion proteins were generated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 14), 'end':(29, 17), 'text':'by inserting either sequence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 18), 'end':(29, 21), 'text':'encoding the full-length protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 22), 'end':(29, 43), 'text':'( EGFP-Bam32 ) , amino acids 1-142 ( EGFP-SH2 ) , or amino acids 133-280 ( EGFP-PH ) into the pEGFP-C1 vector'}, {'start':(29, 44), 'end':(29, 47), 'text':'( Clontech ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 13), 'text':'R61K , R184C , and K197E point mutants were generated with mutant PCR primers'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(30, 14), 'end':(30, 16), 'text':'using the splicing'}, {'label':'joint', 'direction':'None', 'children':[{'start':(30, 17), 'end':(30, 23), 'text':'by overlap extension ( SOE ) method'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 24), 'end':(30, 27), 'text':'and inserted into pEGFP-C1'}, {'start':(30, 28), 'end':(30, 38), 'text':'( PH domain only ) or pcDNA3 ( full-length ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 8), 'text':'The Btk PH domain construct contains amino acids 1-195'}, {'start':(31, 9), 'end':(31, 12), 'text':'inserted into pEGFP-C1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 2), 'text':'Prokaryotic expression vectors'}, {'start':(32, 3), 'end':(32, 15), 'text':'encoding a Bam32 SH2 domain ( amino acids 1-142 ) - glutathione S-transferase'}]}, {'start':(32, 16), 'end':(32, 28), 'text':'( GST ) fusion protein or a full-length Bam32-GST fusion protein were generated'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 29), 'end':(32, 40), 'text':'by inserting the appropriate Bam32 coding sequence into the pGEX 5-x-2 vector'}, {'start':(32, 41), 'end':(32, 46), 'text':'( Amersham Pharmacia Biotech ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 12), 'text':'Fusion proteins were purified with glutathione-sepharose beads ( Amersham Pharmacia Biotech ) ,'}, {'start':(33, 13), 'end':(33, 19), 'text':'according to the manufacturer \'s protocol .'}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 7), 'text':'An anti-Bam32 serum ( 4210K ) was generated'}, {'start':(34, 8), 'end':(34, 16), 'text':'by immunizing rabbits with a Bam32-GST fusion protein .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 11), 'text':'A Bam32 specific mAb ( UW32 ; IgG1 isotype ) was generated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 12), 'end':(35, 19), 'text':'by immunizing mice with Bam32-GST fusion protein ,'}, {'start':(35, 20), 'end':(35, 39), 'text':'followed by fusion with NS-1 cells and ELISA screening of clones for reactivity against Bam32-GST but not GST alone .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 20), 'text':'Other antibodies used were biotinylated phosphotyrosine specific mAb 4G10 ( Upstate Biotechnology ) , anti-myc mAb 9E10 , anti-BLNK mAb 2C9'}, {'start':(36, 21), 'end':(36, 40), 'text':'( Santa Cruz Biotechnology ) , and affinity purified rabbit anti-PLCgamma1 and anti-PLCgamma2 sera ( Santa Cruz Biotechnology ) .'}]}]}, {'start':(37, 0), 'end':(37, 5), 'text':'Transient Transfection of BJAB Cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 38), 'text':'For transient transfection experiments , BJAB cells were resuspended in tissue culture medium at 3 x 10 7 / ml and 400 mul of cells was mixed with the indicated amount of plasmid constructs in a 0.4-cm-gap electroporation cuvette'}, {'start':(38, 39), 'end':(38, 41), 'text':'( Bio-Rad )'}]}, {'start':(38, 42), 'end':(38, 49), 'text':'and incubated on ice for 10 min .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 8), 'text':'Cells were then electroporated using a Gene Pulser apparatus'}, {'start':(39, 9), 'end':(39, 11), 'text':'( Bio-Rad )'}]}, {'start':(39, 12), 'end':(39, 19), 'text':'set at 240 V , 960 muF ,'}]}, {'start':(39, 20), 'end':(39, 28), 'text':'incubated on ice for a further 10 min ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 29), 'end':(39, 36), 'text':'and then transferred to a tissue culture dish'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 37), 'end':(39, 43), 'text':'containing 20 ml of complete RPMI medium'}, {'label':'joint', 'direction':'None', 'children':[{'start':(39, 44), 'end':(39, 50), 'text':'containing 15 % FCS and no antibiotics'}, {'start':(39, 51), 'end':(39, 63), 'text':'and incubated overnight in a 37degreesC , 5 % CO 2 incubator .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 4), 'text':'Cells were then harvested ,'}, {'start':(40, 5), 'end':(40, 6), 'text':'counted ,'}]}, {'start':(40, 7), 'end':(40, 13), 'text':'and used in the indicated assays .'}]}, {'start':(41, 0), 'end':(41, 3), 'text':'Immunoprecipitation and Blotting .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(42, 0), 'end':(42, 14), 'text':'For stimulation experiments , Ramos cells were resuspended at 2 x 10 7 / ml'}, {'start':(42, 15), 'end':(42, 64), 'text':'and stimulated for the indicated periods of time with 10 mug and ml of goat anti-human IgM F ( ab \' ) 2 fragments ( Jackson ImmunoResearch Laboratories ) or 2.5 mM of H 2 O 2 plus 250 muM of sodium orthovanadate ( referred to as pervanadate ) ,'}]}, {'start':(42, 65), 'end':(42, 77), 'text':'washed with 10 vol of ice-cold PBS containing 0.1 % sodium azide ,'}]}, {'start':(42, 78), 'end':(42, 138), 'text':'and lysed at 4 x 10 7 cells and ml in NP-40 lysis buffer ( 150 mM NaCl , 50 mM Tris , pH 8.0 , 5 mM EDTA , 0.5 % NP-40 , protease inhibitors [ 2 mM PMSF , 10 mug and ml aprotinin , 10 mug and ml leupeptin , and 1 mug and ml pepstatin ] ,'}]}, {'start':(42, 139), 'end':(42, 153), 'text':'and phosphatase inhibitors [ 10 mM NaF , 1 mM Na 3 VO 4 ,'}]}, {'start':(42, 154), 'end':(42, 165), 'text':'and 5 mM Na 4 P 2 O 7 ] ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 9), 'text':'Immunoprecipitation , SDS-PAGE , and Western blot analysis were conducted'}, {'start':(43, 10), 'end':(43, 12), 'text':'as described .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 10), 'text':'Far-Western blotting with the Bam32 SH2 domain-GST fusion protein were performed'}, {'start':(44, 11), 'end':(44, 13), 'text':'as described .'}]}, {'start':(45, 0), 'end':(45, 6), 'text':'Confocal Microscopy Analysis of GFP Fusions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 14), 'text':'10 mug of the indicated pEGFP vectors was transfected into BJAB cells by electroporation .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 7), 'text':'After 18-20 h , cells were harvested ,'}, {'start':(47, 8), 'end':(47, 9), 'text':'washed ,'}]}, {'start':(47, 10), 'end':(47, 21), 'text':'and rested overnight in low-serum medium ( 1.25 % FCS ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 10), 'text':'This manipulation reduced the basal membrane association of the PH domain'}, {'start':(48, 11), 'end':(48, 14), 'text':'containing fusion proteins .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 16), 'text':'Cells were then harvested and resuspended at 4-6 x 10 6 / ml in low-serum medium .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(50, 0), 'end':(50, 30), 'text':'Cells were incubated for 30 min at 37degreesC with or without PI3K inhibitors wortmannin ( 20 ng and ml ; Calbiochem ) or LY294002 ( 25 muM ; Calbiochem ) ,'}, {'start':(50, 31), 'end':(50, 53), 'text':'and then stimulated with 10 mug and ml goat anti-human IgM F ( ab \' ) 2 fragments for the indicated time .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 10), 'text':'Cells were then washed in 10 vol of ice-cold PBS ,'}, {'start':(51, 11), 'end':(51, 24), 'text':'fixed in 2 % paraformaldehyde and PBS for 30 min at room temperature ,'}]}, {'start':(51, 25), 'end':(51, 29), 'text':'washed twice in PBS ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 30), 'end':(51, 34), 'text':'and then mounted on slides'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 35), 'end':(51, 39), 'text':'using an aqueous mounting solution'}, {'start':(51, 40), 'end':(51, 48), 'text':'( Aqua Polymount ; Polysciences , Inc. ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 9), 'text':'EGFP fluorescence was examined using a scanning laser confocal microscope'}, {'start':(52, 10), 'end':(52, 20), 'text':'equipped with LaserSharp software ( MRC-1024 system ; Bio-Rad ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 13), 'text':'The ratio of membrane to cytoplasmic EGFP fluorescence intensity was determined from digital images'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 14), 'end':(53, 19), 'text':'using ImageQuant ( R ) software'}, {'start':(53, 20), 'end':(53, 24), 'text':'( Molecular Dynamics ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(54, 0), 'end':(54, 16), 'text':'For each cell , the peak pixel intensity at 4 points on the plasma membrane was averaged'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 17), 'end':(54, 29), 'text':'and divided by the average pixel intensity within a defined area of cytoplasm'}, {'start':(54, 30), 'end':(54, 35), 'text':'( avoiding the nucleus ) .'}]}]}]}]}]}]}]}]}, {'start':(55, 0), 'end':(55, 2), 'text':'Luciferase Assays .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 10), 'text':'BJAB B cells were transfected by electroporation with pcDNA3 expression vectors'}, {'start':(56, 11), 'end':(56, 37), 'text':'containing wild-type or mutant Bam32 and an NF-AT-luciferase reporter construct ( gift from Dr. Gary Koretzky , University of Iowa , Iowa City , IA ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(57, 0), 'end':(57, 6), 'text':'After 18-20 h , cells were harvested'}, {'start':(57, 7), 'end':(57, 19), 'text':'and plated in 96-well plates at 2 x 10 5 / well .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 40), 'text':'Triplicate cultures were incubated in media alone , with 5 mug and ml anti-IgM F ( ab \' ) 2 fragments or 50 nM phorbol-12 ,13 - dibutyrate ( PdBu ; Calbiochem ) and 2.5 muM ionomycin ( Calbiochem ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(59, 0), 'end':(59, 7), 'text':'After 6 h , the cells were lysed'}, {'start':(59, 8), 'end':(59, 15), 'text':'and luciferase activity was measured as described .'}]}]}]}]}]}]}
